Skip to content
MARKETS / NASDAQ / ASPI
NASDAQ · MISCELLANEOUS CHEMICAL PRODUCTS

ASP Isotopes Inc. ASPI

4 fiscal years on record · USD · FY2025 reported · SEC filings only
$23.8M
▲ 475.5% YoY
$-159.8M
$-47.4M
In brief

What this company does

We commenced commercial production of enriched isotopes at both of our ASP enrichment facilities located in Pretoria, South Africa during the first half of 2025. As of December 31, 2025, we employed 271 people on a full-time basis. Of the total employees, 21 employees are in research and development, 122 employees are in engineering, construction and manufacturing, 54 employees are in plant operations and 74 employees are in general management. Our headquarters is located in leased offices in Dallas, Texas.

Written from the business description in ASP Isotopes Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 10 April 2026. Every sentence was checked against that document before publication.

Growth
USD 23.8M
Revenue, FY2025 · full 4-year series below
Revenue $M Net income $M
FY2025 · Revenue 23.8 · Net income -159.8
8M16M-80M2022202320242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−670 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -251.2% · Net -670.2%
-1000%-2000%-3000%2022202320242025
ROE
FY2025 · ROE -126.8%
-50%-100%2022202320242025

Each USD of equity lost 127 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -47.4
-20M-40M2022202320242025
Net buybacks $M Dividends $M
FY2025 · Dividends 0.0 · Net buybacks —
1M2M202320242025

Total assetsUSD 498.0M
EquityUSD 204.2M
CashUSD 285.6M
Gross debtUSD 14.4M
Net debtUSD -271.2M
Current ratio12.23×

The company holds more cash than debt.

The 4-year record
4 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022
Revenue $B0.00.00.00.0
Operating income $B−0.1−0.0−0.0−0.0
EBITDA $B−0.1−0.0−0.0−0.0
Income tax $B0.00.0−0.00.0
Net income $B−0.2−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0
EPS, diluted $−2.11−0.63−0.49·
Dividend / sh $····
Payout %−0−9−0·
ROE %−126.8−101.0−124.8−50.4
Shares out B0.110.070.050.04

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures · 2 divergences in 19 reconciliationsAUDITED

Reconciled in 2 of 19 fiscal years. 2 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 76 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures2 divergent
ActivityMiscellaneous Chemical Products
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2022

Share this section

Download image